PS

Paul Stoffels

Former Chief Scientific Officer, Johnson & Johnson. Co-founder, Former CEO – Chair Galapagos NV

Mechelen, Flemish Region

VC

Invests in

Stages:

Seed
Pre-seed

Sectors:

Locations:

  • Min Investment:

    $0.00

  • Max Investment:

    $0.00

  • Target Investment:

    $0.00

Education

Investments

Frontier Medicines

Series C

Total Funding: $260M

Work Experience

G
Galapagos

2022

  • Advisor

    2025

  • Chief Executive Officer & Chair of the Board of Directors

    2022 - 2025

P
Philips

2018

  • Vice Chair of the Supervisory Board

    2018

J&
Johnson & Johnson

2009 - 2022

  • Chief Scientific Officer

    2012 - 2022

  • Worldwide Chairman, Pharmaceuticals

    2011 - 2016

  • Global Head, Pharmaceutical Reseach and Development

    2009 - 2011